A Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP of the European Pharmacopoeia monograph is often referred to as a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- Certificate of Suitability (COS). The purpose of a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- to their clients by showing that a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP has been issued for it. The manufacturer submits a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP (COS) as part of the market authorization procedure, and it takes on the role of a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP holder for the record. Additionally, the data presented in the Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- DMF.
A Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- suppliers with CEP (COS) on PharmaCompass.